Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02QCC
|
|||
Former ID |
DNC014356
|
|||
Drug Name |
Erythribyssin M
|
|||
Synonyms |
Erythribyssin M; CHEMBL1099090
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C20H20O5
|
|||
Canonical SMILES |
CC1(C(CC2=C(O1)C=CC3=C2OC4C3COC5=C4C=CC(=C5)O)O)C
|
|||
InChI |
1S/C20H20O5/c1-20(2)17(22)8-13-15(25-20)6-5-11-14-9-23-16-7-10(21)3-4-12(16)19(14)24-18(11)13/h3-7,14,17,19,21-22H,8-9H2,1-2H3/t14-,17?,19-/m1/s1
|
|||
InChIKey |
ZCLUCQDBFSBCJB-LJMFKLJISA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Influenza Neuraminidase (Influ NA) | Target Info | Inhibitor | [1] |
KEGG Pathway | Other glycan degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Prenylated pterocarpans as bacterial neuraminidase inhibitors. Bioorg Med Chem. 2010 May 1;18(9):3335-44. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.